PRNewsWire
12 Jun 2026, 02:39 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Enliven Therapeutics has priced an upsized public offering of common stock and pre-funded warrants to raise approximately $400 million in gross proceeds. — Public offerings typically lead to immediate equity dilution for existing shareholders, often putting downward pressure on the stock price.
-0.40Underwriters have been granted a 30-day option to purchase up to an additional 1,600,000 shares of common stock. — The potential for further share issuance creates additional overhang and potential dilution if the option is exercised.
-0.10The offering price for the common stock has been set at $37.50 per share. — This provides a concrete valuation benchmark for the stock, though its impact depends on the previous trading price.
+0.00Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company successfully priced an upsized public offering, raising approximately $400 million in capital.
Goldman Sachs is acting as a joint book-running manager for the offering, generating fee income.
Morgan Stanley is acting as a joint book-running manager for the offering, generating fee income.
Barclays is acting as a joint book-running manager for the offering, generating fee income.
[a_to_b] Goldman Sachs is acting as a joint book-running manager for Enliven Therapeutics' public offering.
[a_to_b] Morgan Stanley is acting as a joint book-running manager for Enliven Therapeutics' public offering.
[a_to_b] Barclays is acting as a joint book-running manager for Enliven Therapeutics' public offering.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
5h ago
